Anteris Technologies Ltd (AVR.AX)
AUD 8.55
(6.88%)
AUD 8.55
(6.88%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 69.14 Million AUD | 41.19% |
| 2022 | 25.8 Million AUD | 81.77% |
| 2021 | 14.19 Million AUD | 31.73% |
| 2020 | 10.77 Million AUD | -8.76% |
| 2019 | 11.81 Million AUD | -66.96% |
| 2018 | 35.74 Million AUD | 16.06% |
| 2017 | 30.8 Million AUD | 323.05% |
| 2016 | 7.28 Million AUD | -76.01% |
| 2015 | 30.34 Million AUD | 13.78% |
| 2014 | 26.67 Million AUD | 51.01% |
| 2013 | 17.66 Million AUD | 120.72% |
| 2012 | 8 Million AUD | 14.85% |
| 2011 | 6.96 Million AUD | 110.8% |
| 2010 | 3.3 Million AUD | 121.36% |
| 2009 | 1.49 Million AUD | 13.95% |
| 2008 | 1.31 Million AUD | -10.36% |
| 2007 | 1.46 Million AUD | -8.47% |
| 2006 | 1.59 Million AUD | 44.23% |
| 2005 | 1.1 Million AUD | 25.38% |
| 2004 | 883.07 Thousand AUD | 23.45% |
| 2003 | 715.35 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 53.24 Million AUD | 0.0% |
| 2023 Q4 | 17.3 Million AUD | 0.0% |
| 2023 Q2 | 19.12 Million AUD | 0.0% |
| 2023 FY | 36.43 Million AUD | 41.19% |
| 2022 Q4 | 12.58 Million AUD | 0.0% |
| 2022 Q2 | 15.06 Million AUD | 0.0% |
| 2022 FY | 25.8 Million AUD | 81.77% |
| 2021 FY | 14.19 Million AUD | 31.73% |
| 2021 Q2 | 5.43 Million AUD | 0.0% |
| 2021 Q4 | 8.76 Million AUD | 0.0% |
| 2020 Q2 | 5.52 Million AUD | 0.0% |
| 2020 Q4 | 5.24 Million AUD | 0.0% |
| 2020 FY | 10.77 Million AUD | -8.76% |
| 2019 Q2 | 5.89 Million AUD | 0.0% |
| 2019 Q4 | 6.69 Million AUD | 0.0% |
| 2019 FY | 11.81 Million AUD | -66.96% |
| 2018 Q4 | 18.51 Million AUD | 0.0% |
| 2018 FY | 35.74 Million AUD | 16.06% |
| 2018 Q2 | 17.23 Million AUD | 0.0% |
| 2017 FY | 30.8 Million AUD | 323.05% |
| 2017 Q2 | 10.36 Million AUD | 0.0% |
| 2016 Q2 | 14.39 Million AUD | 0.0% |
| 2016 Q4 | 12.69 Million AUD | 0.0% |
| 2016 FY | 7.28 Million AUD | -76.01% |
| 2015 Q4 | 15.94 Million AUD | 0.0% |
| 2015 FY | 30.34 Million AUD | 13.78% |
| 2015 Q2 | 13.22 Million AUD | 0.0% |
| 2014 FY | 26.67 Million AUD | 51.01% |
| 2014 Q2 | 8.84 Million AUD | 0.0% |
| 2014 Q4 | 13.44 Million AUD | 0.0% |
| 2013 FY | 17.66 Million AUD | 120.72% |
| 2013 Q4 | 3.44 Million AUD | 0.0% |
| 2013 Q2 | 2.27 Million AUD | 0.0% |
| 2012 Q2 | 572.09 Thousand AUD | 0.0% |
| 2012 Q1 | 572.09 Thousand AUD | 0.0% |
| 2012 FY | 8 Million AUD | 14.85% |
| 2012 Q4 | 4.29 Million AUD | 649.97% |
| 2012 Q3 | 572.09 Thousand AUD | 0.0% |
| 2011 Q2 | 96.74 Thousand AUD | 0.0% |
| 2011 Q3 | 96.74 Thousand AUD | 0.0% |
| 2011 Q4 | 572.09 Thousand AUD | 491.37% |
| 2011 FY | 6.96 Million AUD | 110.8% |
| 2011 Q1 | 96.74 Thousand AUD | 0.0% |
| 2010 FY | 3.3 Million AUD | 121.36% |
| 2010 Q3 | -327.91 Thousand AUD | 0.0% |
| 2010 Q4 | 96.74 Thousand AUD | 129.5% |
| 2010 Q2 | -327.91 Thousand AUD | 0.0% |
| 2010 Q1 | -327.91 Thousand AUD | 0.0% |
| 2009 Q3 | -295.72 Thousand AUD | 0.0% |
| 2009 Q4 | -327.91 Thousand AUD | -10.89% |
| 2009 Q2 | -295.72 Thousand AUD | 0.0% |
| 2009 FY | 1.49 Million AUD | 13.95% |
| 2009 Q1 | -295.72 Thousand AUD | 0.0% |
| 2008 Q3 | -335.23 Thousand AUD | 0.0% |
| 2008 FY | 1.31 Million AUD | -10.36% |
| 2008 Q4 | -295.72 Thousand AUD | 11.78% |
| 2008 Q2 | -335.23 Thousand AUD | 0.0% |
| 2008 Q1 | -335.23 Thousand AUD | 0.0% |
| 2007 Q1 | -662.41 Thousand AUD | 0.0% |
| 2007 Q4 | -335.23 Thousand AUD | 49.39% |
| 2007 FY | 1.46 Million AUD | -8.47% |
| 2007 Q3 | -662.41 Thousand AUD | 0.0% |
| 2007 Q2 | -662.41 Thousand AUD | 0.0% |
| 2006 Q3 | -277.86 Thousand AUD | 0.0% |
| 2006 Q4 | -662.41 Thousand AUD | -138.39% |
| 2006 FY | 1.59 Million AUD | 44.23% |
| 2006 Q1 | -277.86 Thousand AUD | 0.0% |
| 2006 Q2 | -277.86 Thousand AUD | 0.0% |
| 2005 Q4 | -277.86 Thousand AUD | 68.56% |
| 2005 FY | 1.1 Million AUD | 25.38% |
| 2005 Q1 | -883.88 Thousand AUD | 0.0% |
| 2005 Q2 | -883.88 Thousand AUD | 0.0% |
| 2005 Q3 | -883.88 Thousand AUD | 0.0% |
| 2004 Q3 | -178.83 Thousand AUD | 0.0% |
| 2004 FY | 883.07 Thousand AUD | 23.45% |
| 2004 Q2 | -178.83 Thousand AUD | 0.0% |
| 2004 Q4 | -883.88 Thousand AUD | -394.24% |
| 2004 Q1 | -178.83 Thousand AUD | 0.0% |
| 2003 FY | 715.35 Thousand AUD | 0.0% |
| 2003 Q4 | -178.83 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| 4DMedical Limited | 31.48 Million AUD | -119.636% |
| Adherium Limited | 267.7 Thousand AUD | -25730.802% |
| Aroa Biosurgery Limited | 66.09 Million AUD | -4.614% |
| Atomo Diagnostics Limited | 1.6 Million AUD | -4205.71% |
| Control Bionics Limited | 9.82 Million AUD | -603.749% |
| CardieX Limited | 16.64 Million AUD | -315.34% |
| Compumedics Limited | 26.88 Million AUD | -157.254% |
| Cochlear Limited | 1.17 Billion AUD | 94.113% |
| CleanSpace Holdings Limited | 11.35 Million AUD | -508.75% |
| Cyclopharm Limited | 13.38 Million AUD | -416.783% |
| EMVision Medical Devices Ltd | 12.83 Million AUD | -438.818% |
| Nova Eye Medical Limited | 23.99 Million AUD | -188.244% |
| HeraMED Limited | 6.78 Million AUD | -919.464% |
| Imricor Medical Systems, Inc. | -1.11 Million AUD | 6297.116% |
| ImpediMed Limited | 28.04 Million AUD | -146.603% |
| InhaleRx Limited | 2.59 Million AUD | -2569.328% |
| LBT Innovations Limited | 1.1 Million AUD | -6146.597% |
| Micro-X Limited | 18.76 Million AUD | -268.524% |
| Neurotech International Limited | 8.75 Million AUD | -689.896% |
| OncoSil Medical Limited | 12.03 Million AUD | -474.342% |
| PolyNovo Limited | 34.92 Million AUD | -98.012% |
| Respiri Limited | 8.03 Million AUD | -760.623% |
| SomnoMed Limited | 58.97 Million AUD | -17.258% |
| Universal Biosensors, Inc. | 20 Million AUD | -245.745% |
| Uscom Limited | 5.52 Million AUD | -1152.704% |
| Visioneering Technologies, Inc. | 9.63 Million AUD | -617.796% |